Articles

Oct
18

“The challenge of modernity is to live without illusions and without becoming disillusioned.” ––Antonio Gramsci Protection of emergent works is impossible. Without an author, there is no expression of ideas which can be original, and thus no copyrightable work. Indeed, the whole system of copyright law, its conceptual building blocks of idea-expression dichotomy, originality, authorship,

Oct
18

Quality of life challenges presented by the COVID-19 pandemic emphasized the importance of making access to voice and broadband data services widespread and affordable. The virus forced nearly everyone to shelter in place and to rely on wired and wireless technologies for remote access to education, telehealth, government services, social networks, ecommerce, entertainment, and communications.

Oct
18

The legal regimes governing biotechnology and climate change took shape at approximately the same time, but for their first twenty years the two were viewed as independent of one another, with few if any areas of overlap. But in the years since, their potential areas of interconnection have started to grow. And within the last

May
17

OpenAI, an artificial intelligence (“AI”) developer, captured the attention of technology companies, consumers, and policymakers when it released an updated version of its AI-enabled chatbot ChatGPT in December 2022. Weeks after the release, a Member of Congress introduced a non-binding resolution calling for a nimble and flexible government agency to oversee AI development to manage

May
17

For years, entrepreneurs have raised capital from angel investors and venture capitalists through staged financings. In each round of financing, the entrepreneur recruits a lead investor who negotiates the deal terms of the investment on behalf of all investors. From there, the lead investor assists the startup venture by recruiting other investors to join them

May
17

Organ bioprinting involves using cells and biomaterials to 3D print structures that resemble and imitate the functions of natural organs. Since bioprinting is a relatively new technological advancement, there is a lack of regulatory structure in the United States, despite regulatory structures around the globe that are more developed in this field. Because of bioprinting’s

May
17

Artificial intelligence (“AI”) has the potential to revolutionize entire industry sectors and provide substantial economic and social benefits to American works and consumers. Although the AI legal and regulatory landscape is still in its early stages and the regulatory void seems to be widening, many private initiatives have embraced self-regulation to foster responsible AI development

Categories